SIRT3 and metabolic dysfunction-associated steatotic liver disease: The latest studies demonstrated that DMY elevated SIRT3 expression to improve hypoxic hypoxia-induced memory and to attenuate the hepatic injury in nonalcoholic fatty liver disease [23,24].